Suppr超能文献

黑色素对奈替米星诱导的人皮肤成纤维细胞胶原蛋白生物合成抑制作用的影响。

Effect of melanin on netilmicin-induced inhibition of collagen biosynthesis in human skin fibroblasts.

作者信息

Buszman Ewa, Wrześniok Dorota, Surazyński Arkadiusz, Pałka Jerzy, Moleda Katarzyna

机构信息

Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Medical University of Silesia, Jagiellońska 4, PL 41-200 Sosnowiec, Poland.

出版信息

Bioorg Med Chem. 2006 Dec 15;14(24):8155-61. doi: 10.1016/j.bmc.2006.09.027. Epub 2006 Sep 28.

Abstract

It is known that various drugs form complexes with melanins and that melanins are abundant constituents of the inner ear. In this study, we determined whether the aminoglycoside antibiotic, netilmicin, interacts with melanin and how this process affects collagen biosynthesis in cultured human skin fibroblasts. The obtained results indicate that netilmicin forms stable complexes with melanin characterized by the association constants K(1) approximately 10(6)M(-1) and K(2) approximately 10(3)M(-1). We have suggested that prolidase, an enzyme involved in collagen metabolism, may be one of the targets for aminoglycoside-induced inhibition of collagen biosynthesis. We found that netilmicin strongly induced inhibition of prolidase activity (IC(50)<5microM) and collagen biosynthesis (IC(50) approximately 10microM). At 10microM concentration of netilmicin, prolidase activity in human skin fibroblasts was inhibited by about 80% and DNA biosynthesis-only by about 25%. Melanin at 100microg/mL produced about 30% inhibition of collagen biosynthesis and about 30% inhibition of prolidase activity in cultured fibroblasts. However, the addition of melanin (100microg/mL) to netilmicin-treated cells (10microM) restored the prolidase activity in fibroblasts to almost 100% of control values and partially reversed the inhibitory action of the drug on collagen and DNA biosynthesis. The data suggest that the ability of netilmicin to form stable complexes with melanin may prevent its toxicity on prolidase activity and collagen biosynthesis.

摘要

已知多种药物可与黑色素形成复合物,且黑色素是内耳的丰富成分。在本研究中,我们确定了氨基糖苷类抗生素奈替米星是否与黑色素相互作用,以及该过程如何影响培养的人皮肤成纤维细胞中的胶原蛋白生物合成。所得结果表明,奈替米星与黑色素形成稳定复合物,其结合常数K(1)约为10(6)M(-1),K(2)约为10(3)M(-1)。我们认为,参与胶原蛋白代谢的酶——脯氨酰二肽酶,可能是氨基糖苷类药物诱导胶原蛋白生物合成抑制作用的靶点之一。我们发现,奈替米星强烈诱导脯氨酰二肽酶活性的抑制(IC(50)<5μM)和胶原蛋白生物合成的抑制(IC(50)约为10μM)。在奈替米星浓度为10μM时,人皮肤成纤维细胞中的脯氨酰二肽酶活性被抑制约80%,而DNA生物合成仅被抑制约25%。100μg/mL的黑色素在培养的成纤维细胞中对胶原蛋白生物合成产生约30%的抑制,对脯氨酰二肽酶活性产生约30%的抑制。然而,向经奈替米星处理的细胞(10μM)中添加黑色素(100μg/mL)可使成纤维细胞中的脯氨酰二肽酶活性恢复至几乎100%的对照值,并部分逆转该药物对胶原蛋白和DNA生物合成的抑制作用。数据表明,奈替米星与黑色素形成稳定复合物的能力可能会阻止其对脯氨酰二肽酶活性和胶原蛋白生物合成的毒性作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验